Age, years | Â |
---|---|
   Mean (range) | 48.0 (32 to 70) |
Type of BRCA1 mutation | Â |
5382insC | 13 |
C61G | 6 |
153delA | 1 |
Year of initial treatment | Â |
2000 to 2003 | 2 |
2004 to 2006 | 7 |
2007 to 2009 | 11 |
Estrogen receptor | Â |
   Positive | 5 |
   Negative | 15 |
Progesterone receptor | Â |
   Positive | 3 |
   Negative | 17 |
HER2 status | Â |
   Positive | 0 |
   Negative | 20 |
Histology | Â |
   Ductal | 11 |
   Medullary | 7 |
   Other | 1 |
   Missing | 1 |
Prior adjuvant chemotherapy | Â |
Yes | 13 |
No | 7 |
Sites of metastases | Â |
Liver | 10 |
Lung | 9 |
Bone | 3 |
Other | 11 |
Number of sites of metastases | Â |
1 | 12 |
2 | 4 |
3 | 2 |
4+ | 2 |
Prior chemotherapy for metastatic disease | Â |
Yes | 11 |
No | 9 |
Line of therapy of metastatic disease | Â |
1 | 9 |
2 | 2 |
3 | 8 |
4 | 1 |